文献速递颅颌面外科美容整形

计算机自适应测试应用于FACE-Q皮肤癌模块:面部手术患者报告结局的个体化

Applying Computerized Adaptive Testing to the FACE-Q Skin Cancer Module: Individualizing Patient-Reported Outcome Measures in Facial Surgery.
PubMed 文献 · Plast Reconstr Surg · 2021-01-01

该研究旨在利用计算机自适应测试减少FACE-Q皮肤癌模块的条目数量,以降低患者负担。模拟结果显示,条目数从原41项降至平均23±0.55项,且与固定长度短表得分保持高相关(0.98-0.99)。结论认为该方法可缩短评估长度50%以上而几乎不损失精确度。

要点

  • 计算机自适应测试可将FACE-Q皮肤癌模块条目从41项减至平均23项。
  • 模拟CAT得分与原固定短表得分相关性高达0.98-0.99。
  • 该方法有望减少患者负担并促进临床实践中的实施。

核心结论

  • 将计算机自适应测试应用于FACE-Q皮肤癌模块可将评估长度减少50%以上,且几乎不损失精确度。

研究设计与样本

  • 使用开源计算机自适应测试模拟软件,对FACE-Q皮肤癌模块的5个量表(瘢痕评估、面部外观满意度、外观相关心理社会困扰、癌症担忧、外观信息满意度)进行条目反应模拟,直至达到预设的精确度水平(由标准误估计)。

主要发现

  • 患者完成FACE-Q皮肤肿瘤模块所需问题数从原版的41项降至计算机自适应测试版本的平均23±0.55项(范围15至29项)。
  • 模拟的计算机自适应测试得分与固定长度短表得分保持高相关(0.98至0.99)。

临床怎么用

  • 计算机自适应测试可用于减少FACE-Q皮肤癌模块的评估负担,有望在临床实践中实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Skin cancer is among the most frequently occurring malignancies worldwide, which creates a great need for an effective patient-reported outcome measure. Providing shorter questionnaires reduces patient burden and increases patients' willingness to complete forms. The authors set out to use computerized adaptive testing to reduce the number of items needed to predict results for scales of the FACE-Q Skin Cancer Module, a validated patient-reported outcome measure that measures health-related quality of life and patient satisfaction in facial surgery. METHODS: Computerized adaptive testing generates tailored questionnaires for patients in real time based on their responses to previous questions. The authors used an open-source computerized adaptive testing simulation software to run item responses for the five scales from the FACE-Q Skin Cancer Module (i.e., scar appraisal, satisfaction with facial appearance, appearance-related psychosocial distress, cancer worry, and satisfaction with information about appearance). Each simulation continued to administer items until prespecified levels of precision were met, estimated by standard error. Mean and maximum item reductions between the original fixed-length short forms and the simulated versions were evaluated. RESULTS: The number of questions that patients needed to answer to complete the FACE-Q Skin Oncology Module was reduced from 41 items in the original form to a mean of 23 ± 0.55 items (range, 15 to 29) using the computerized adaptive testing version. Simulated computerized adaptive testing scores maintained a high correlation (0.98 to 0.99) with the score from the fixed-length short forms. CONCLUSIONS: Applying computerized adaptive testing to the FACE-Q Skin Cancer Module can reduce the length of assessment by more than 50 percent, with virtually no loss in precision. It is likely to play a critical role in the implementation in clinical practice.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Ottenhof MJ, Geerards D, Harrison C, et al. Applying Computerized Adaptive Testing to the FACE-Q Skin Cancer Module: Individualizing Patient-Reported Outcome Measures in Facial Surgery. Plast Reconstr Surg. 2021. PMID: 34415858. doi:10.1097/PRS.0000000000008326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。